Biomedicine and Molecular Biosciences (BMBS)
Actions
This section gives an overview of past and running Actions within this Domain with descriptions as provided by the COST Actions. Click on the Action of your interest or use the detailed search option in the top right corner of your screen or on the Actions tab of the Quick Access menu on the homepage.
- TD1104 | European network for development of electroporation-based technologies and treatments (EP4Bio2Med)
- BM1106 | The Genes in Irritable Bowel Syndrome Research Network Europe (GENIEUR)
- BM1105 | GnRH deficiency: Elucidation of the neuroendocrine control of human reproduction
- TD1101 | A Collaborative European Network on Rabbit Genome Biology (RGB-Net)
- BM1104 | Mass Spectrometry Imaging: New Tools for Healthcare Research
- BM1103 | Arterial spin labelling Initiative in Dementia (AID)
- BM1102 | Ciliates as model systems to study genome evolution, mechanisms of non-Mendelian inheritance, and their roles in environmental adaptation
- BM1101 | European network for the study of dystonia syndromes
- TD1006 | European Network on Robotics for NeuroRehabilitation
- BM1007 | Mast Cells and Basophils - Targets for Innovative Therapies
- BM1006 | Next Generation Sequencing Data Analysis Network
- BM1005 | Gasotransmitters: from basic science to therapeutic applications (ENOG: European Network on Gasotransmitters)
- TD1002 | European network on applications of Atomic Force Microscopy to NanoMedicine and Life Sciences (AFM4NanoMed&Bio)
- BM1004 | Enhancing the scientific study of early autism: A network to improve research, services and outcomes
- BM1003 | Microbial cell surface determinants of virulence as targets for new therapeutics in Cystic Fibrosis
- BM1002 | Nanomechanics of intermediate filament networks (NANONET)
- BM1001 | Brain Extracellular Matrix in Health and Disease (ECMNet)
- BM0907 | European Network for Translational Immunology Research and Education (ENTIRE): From immunomonitoring to personalized immunotherapy
- BM0906 | Regulatory RNAs in bacterial pathogenicity: new targets for alternative therapies
- BM0905 | European Network for the Study of Gilles de la Tourette Syndrome
